Debate - Guidelines for GRE control - The case of optimism

Journal of Hospital Infection

Volumn 57, Issue 4, 2004, Pages 285-289

  Barrett, S P ^a  

^a CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

Enterococci; Glycopeptide resistance; Infection control guidelines

Indexed keywords

ANTIBIOTIC AGENT; CEFTAZIDIME; METICILLIN; POLYPEPTIDE ANTIBIOTIC AGENT;

ARTICLE; DRUG USE; ENTEROCOCCUS; HUMAN; INFECTION CONTROL; MEDICAL LITERATURE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PRACTICE GUIDELINE; PREVALENCE;

ANTI-BACTERIAL AGENTS; CROSS INFECTION; DRUG RESISTANCE, MICROBIAL; DRUG UTILIZATION; ENDEMIC DISEASES; ENTEROCOCCUS; EVIDENCE-BASED MEDICINE; GLYCOPEPTIDES; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; HYGIENE; INFECTION CONTROL; METHICILLIN RESISTANCE; OUTCOME ASSESSMENT (HEALTH CARE); POPULATION SURVEILLANCE; PRACTICE GUIDELINES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; WORLD HEALTH;

EID: 3543124223     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhin.2003.10.007     Document Type: Article

References (33)

1. Leclercq R. Derlot E. Duval J. Courvalin P. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium N Engl J Med 319 1988 157-161
2. Jevons M.P. Celbenin resistant staphylococci BMJ 1 1961 124-125
3. Enright M.C. Robinson D.A. Randle G. Feil E.J. Grundmann H. Spratt B.G. The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA) Proc Natl Acad Sci USA 99 2002 7687-7692
4. Cetinkaya Y. Falk P. Mayhall C.G. Vancomycin-resistant enterococci Clin Microbiol Rev 13 2000 686-707
5. Schoonmaker D.J. Bopp L.H. Baltch A.L. Smith R.P. Rafferty M.E. George M. Genetic analysis of multiple vancomycin-resistant enterococcus isolates obtained serially from two long-term-care patients J Clin Microbiol 36 1998 2105-2108
6. Montecalvo M.A. Jarvis W.R. Uman J. et al. Infection-control measures reduce transmission of vancomycin-resistant enterococci in an endemic setting Ann Intern Med 131 1999 269-272
7. Nourse C. Murphy H. Byrne C. et al. Control of a nosocomial outbreak of vancomycin resistant Enterococcus faecium in a paediatric oncology unit: risk factors for colonisation Eur J Pediatr 157 1998 20-27
8. Bager F. Madsen M. Christensen J. Aarestrup F.M. Avoparcin used as a growth promoter is associated with the occurrence of vancomycin-resistant Enterococcus faecium on Danish poultry and pig farms Prev Vet Med 31 1997 95-112
9. Aarestrup F.M. Seyfarth A.M. Emborg H.D. Pedersen K. Hendriksen R.S. Bager F. Effect of abolishment of the use of antimicrobial agents for growth promotion on occurrence of antimicrobial resistance in fecal enterococci from food animals in Denmark Antimicrob Agents Chemother 45 2001 2054-2059
10. Schouten M.A. Voss A. Hoogkamp-Korstanje J.A. VRE and meat Lancet 349 1997 1258
11. Klare I. Badstubner D. Konstabel C. Bohme G. Claus H. Witte W. Decreased incidence of VanA-type vancomycin-resistant enterococci isolated from poultry meat and from fecal samples of humans in the community after discontinuation of avoparcin usage in animal husbandry Microb Drug Resist 5 1999 45-52
12. National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1990-May 1999, issued June 1999 Am J Infect Control 27 1999 520-532
13. Kirst H.A. Thompson D.G. Nicas T.I. Historical yearly usage of vancomycin Antimicrob Agents Chemother 42 1998 1303-1304
14. Van der Auwera P. Pensart N. Korten V. Murray B.E. Leclercq R. Influence of oral glycopeptides on the fecal flora of human volunteers: selection of highly glycopeptide-resistant enterococci J Infect Dis 173 1996 1129-1136
15. Hospital Infection Control Practices Advisory Committee Recommendations for preventing the spread of vancomycin resistance Infect Control Hosp Epidemiol 16 1995 105-113
16. Anglim A.M. Klym B. Byers K.E. Scheld W.M. Farr B.M. Effect of a vancomycin restriction policy on ordering practices during an outbreak of vancomycin-resistant Enterococcus faecium Arch Intern Med 157 1997 1132-1136
17. Harthug S. Jureen R. Mohn S.C. et al. The prevalence of faecal carriage of ampicillin-resistant and high-level gentamicin-resistant enterococci among inpatients at 10 major Norwegian hospitals J Hosp Infect 50 2002 145-154
18. Donskey M.D. Tanvir K. Chowdhry M.D. et al. Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients N Engl J Med 343 2000 1925-1932
19. Bradley S.J. Wilson A.L. Allen M.C. Sher H.A. Goldstone A.H. Scott G.M. The control of hyperendemic glycopeptide-resistant Enterococcus spp. on a haematology unit by changing antibiotic usage J Antimicrob Chemother 43 1999 261-266
20. Revised guidelines for the control of methicillin-resistant Staphylococcus aureus infection in hospitals. British Society for Antimicrobial Chemotherapy, Hospital Infection Society and the Infection Control Nurses Association. J Hosp Infect 1998; 39: 253-290.
21. Cooper B.S. Medley G.F. Scott G.M. Preliminary analysis of the transmission dynamics of nosocomial infections: stochastic and management effects J Hosp Infect 43 1999 131-147
22. D'Agata E.M. Horn M.A. Webb G.F. The impact of persistent gastrointestinal colonization on the transmission dynamics of vancomycin-resistant enterococci J Infect Dis 185 2002 766-773
23. Shaikh Z.H. Osting C.A. Hanna H.A. Arbuckle R.B. Tarr J.J. Raad I.I. Effectiveness of a multifaceted infection control policy in reducing vancomycin usage and vancomycin-resistant enterococci at a tertiary care cancer centre J Hosp Infect 51 2002 52-58
24. Sandoe J.A. Hall J.M. Collyns T.A. et al. An outbreak of vancomycin-resistant enterococci associated with major ward refurbishment J Hosp Infect 50 2002 79-80
25. Boyce J.M. Opal S.M. Chow J.W. et al. Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance J Clin Microbiol 32 1994 1148-1153
26. Mayer R.A. Geha R.C. Helfand M.S. Hoyen C.K. Salata R.A. Donskey C.J. Role of fecal incontinence in contamination of the environment with vancomycin-resistant enterococci Am J Infect Control 31 2003 221-225
27. Falk P.S. Winnike J. Woodmansee C. Desai M. Mayhall C.G. Outbreak of vancomycin-resistant enterococci in a burn unit Infect Control Hosp Epidemiol 21 2000 575-582
28. Srinivasan A. Song X. Ross T. Merz W. Brower R. Perl T.M. A prospective study to determine whether cover gowns in addition to gloves decrease nosocomial transmission of vancomycin-resistant enterococci in an intensive care unit Infect Control Hosp Epidemiol 23 2002 424-428
29. Sakagami Y. Kajimura K. Bactericidal activities of disinfectants against vancomycin-resistant enterococci J Hosp Infect 50 2002 140-144
30. Monnet D.L. Antimicrobial resistance in Europe. Conference Proceedings-Global Consensus Conference on Infection Control Issues Related to Antimicrobial Resistance. APIC, CHICA-Canada, ICNA. March 19-21, Washington, DC: APIC; 1999. pp. 7-10.
31. van den Braak N. Ott A. van Belkum A. et al. Prevalence and determinants of fecal colonization with vancomycin-resistant enterococcus in hospitalized patients in The Netherlands Infect Control Hosp Epidemiol 21 2000 520-524
32. Ridwan B. Mascini E. van der Reijden N. Verhoef J. Bonten M. What action should be taken to prevent spread of vancomycin resistant enterococci in European hospitals? BMJ 324 2002 666-668
33. Vriens M. Blok H. Fluit A. Troelstra A. Van Der Werken C. Verhoef J. Costs associated with a strict policy to eradicate methicillin-resistant Staphylococcus aureus in a Dutch University Medical Center: a 10-year survey Eur J Clin Microbiol Infect Dis 21 2002 782-786